Although they are usually viewed as the first line of defense in response to injury, inflammation, or disease (Nayak et al., 2014), microglia, the brain immunocompetent cells, have emerged as major contributors of brain development as well as homeostasis throughout life (Cuadros et al., 1994; Lenz & McCarthy, 2014). Microglia are myeloid cells originating from the yolk sac that start colonizing the developing brain around embryonic day 9.5-10.5 in rodents (Ginhoux et al., 2010) and as early as 4.5 gestational weeks in humans (Verney et al., 2010). They enter the brain via the ventricles, meninges, and developing blood vessels under an immature ameboid form (Thion & Garel, 2017). They migrate and proliferate through the nervous system parenchyma (Nikodemova et al., 2015; Tay et al., 2016), then progressively transition to ramified microglia as they reach their final location (Lannes et al., 2017; Thion et al., 2018). After the formation of the blood-brain barrier, microglia proliferate by self-renewal throughout life (Ajami et al.,